Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132803) titled 'Randomized, Open-label, Single-dose, Two-period, Double- crossover Bioequivalence Study of Tofacitinib Citrate Extended-release Tablets in Healthy Subjects Under Fasting and Postprandial Conditions' on Sept. 18.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Zhejiang Hospital
Condition:
Autoimmune diseases like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
Intervention:
T-R Group(High-meal fed) :test preparation in the first period
reference preparation in the second period
T-R Group (Fasting):test preparation in the first period
reference preparation in...